Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Mannitol Patent Expiration

Mannitol is Used for assessing bronchial hyperresponsiveness in patients over 6 years old without clinically apparent asthma. It was first introduced by B Braun Medical Inc in its drug Mannitol 5% on Approved Prior to Jan 1, 1982. Other drugs containing Mannitol are Osmitrol 20% In Water In Plastic Container, Mannitol 25%, Mannitol 20% In Plastic Container, Mannitol 20%, Osmitrol 15% In Water, Bronchitol, Mannitol 5% In Plastic Container, Resectisol, Osmitrol 10% In Water, Mannitol 5% W/ Dextrose 5% In Sodium Chloride 0.12%, Mannitol 15%, Osmitrol 15% In Water In Plastic Container, Mannitol 10%, Osmitrol 5% In Water In Plastic Container, Mannitol 15% W/ Dextrose 5% In Sodium Chloride 0.45%, Mannitol 10% In Plastic Container, Osmitrol 5% In Water, Aridol Kit, Osmitrol 10% In Water In Plastic Container, Resectisol In Plastic Container, Mannitol 15% In Plastic Container, Osmitrol 20% In Water, Mannitol 10% W/ Dextrose 5% In Distilled Water. 13 different companies have introduced drugs containing Mannitol.


Mannitol Patents

Given below is the list of patents protecting Mannitol, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Aridol Kit US5817028 Method and device for the provocation of air passage narrowing and/or the induction of sputum Feb 23, 2015

(Expired)

 Pharmaxis Europe



Mannitol's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Mannitol Generic API Manufacturers

Several generic applications have been filed for Mannitol. The first generic version for Mannitol was by Fresenius Kabi Usa Llc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Igi Laboratories Inc and was approved on May 6, 1987.

Given below is the list of companies who have filed for Mannitol generic, along with the locations of their manufacturing plants worldwide.


1. ABRAXIS PHARM

Abraxis Pharmaceutical Products has filed for 1 generic for Mannitol. This 12.5gm/50ml version comes by the name MANNITOL 25%. Given below are the details of the strengths of this generic introduced by Abraxis Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
12.5GM/50ML

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982





2. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 1 generic for Mannitol. This 12.5gm/50ml version comes by the name MANNITOL 25%. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
12.5GM/50ML

injectable Prescription INJECTION AP Approved Prior to Jan 1, 1982


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Bensenville Fresenius Kabi USA LLC (FK USA)
Skokie Fresenius Kabi USA LLC
North Andover Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA LLC
Melrose Park Fresenius Kabi USA, LLC
Lake Zurich Fresenius Kabi USA, LLC
Wilson Fresenius Kabi USA, LLC
Grand Island Fresenius Kabi USA, LLC





3. IGI LABS INC

Igi Laboratories Inc has filed for 1 generic for Mannitol. This 12.5gm/50ml version comes by the name MANNITOL 25%. Given below are the details of the strengths of this generic introduced by Igi Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
12.5GM/50ML

injectable Discontinued INJECTION N/A May 6, 1987





4. INTL MEDICATION

International Medication System has filed for 1 generic for Mannitol. This 12.5gm/50ml version comes by the name MANNITOL 25%. Given below are the details of the strengths of this generic introduced by Intl Medication.

Strength Dosage Form Availability Application Pathway TE code Launch Date
12.5GM/50ML

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982





5. LUITPOLD

Luitpold Pharmaceuticals Inc has filed for 1 generic for Mannitol. This 12.5gm/50ml version comes by the name MANNITOL 25%. Given below are the details of the strengths of this generic introduced by Luitpold.

Strength Dosage Form Availability Application Pathway TE code Launch Date
12.5GM/50ML

injectable Discontinued INJECTION N/A Jan 21, 1982





6. WATSON LABS

Watson Laboratories Inc has filed for 1 generic for Mannitol. This 12.5gm/50ml version comes by the name MANNITOL 25%. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
12.5GM/50ML

injectable Discontinued INJECTION N/A Jun 27, 1983